AlexanderKuoMD

PubMed

• Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry.
  Kuo, A.,Gomel, R.,Safer, R.,Lindor, K. D.,Everson, G. T.,Bowlus, C. L.> ;Clin. Gastroenterol. Hepatol.. 2018 May 01
• Safety and Efficacy of Current DAA Regimens in Kidney and Liver Transplant Recipients with Hepatitis C: Results from the HCV-TARGET Study.
  Saxena, V.,Khungar, V.,Verna, E. C.,Levitsky, J.,Brown, R. S.,Hassan, M. A.,Sulkowski, M. S.,O'Leary, J. G.,Koraishy, F.,Galati, J. S.,Kuo, A. A.,Vainorius, M.,Akushev...> ;Hepatology. 2017 May 16
• Effectiveness and Safety of Sofosbuvir plus Ribavirin for the Treatment of HCV Genotype 2 Infection: Results of the Real-World, Clinical Practice HCV-TARGET Study
  Alexander Kuo, Jama Darling, Joseph S Galati, Michael W Fried, Giuseppe Morelli, Rajender K Reddy, Mark S Sulkowski, David R Nelson, Saleh Alqahtani, Paul Pockros> ;Emergency Medicine Journal. 2016 Jul 16